Is local resection sufficient for parathyroid carcinoma? by Basceken, Salim Ilksen et al.
Is local resection sufficient for parathyroid carcinoma?
Salim Ilksen Basceken,I Volkan Genc,II Siyar Ersoz,III Yusuf Sevim,IV Suleyman Utku Celik,II
Ilknur Kepenekci BayramII
IGeneral Surgery, Islahiye State Hospital, Gaziantep, Turkey. IIAnkara University Medical School, Department of General Surgery, Ankara, Turkey. IIIAnkara
Numune Training and Research Hospital, Department of General Surgery, Ankara, Turkey. IVGeneral Surgery, Ankara Penal Institution Campus State
Hospital, Ankara, Turkey.
OBJECTIVES: Parathyroid carcinoma is a rare malignant disease of the parathyroid glands that appears in less
than 1% of patients with primary hyperparathyroidism. In the literature, the generally recommended treatment
is en bloc tumor excision with ipsilateral thyroid lobectomy. Based on our 12 years of experience, we discuss the
necessity of performing thyroid lobectomy on parathyroid carcinoma patients.
RESULTS: Eleven parathyroid carcinoma cases were included in the study. All operations were performed at the
Department of Endocrine Surgery at Ankara University Medical School. Seven of the patients were male
(63.6%), and the mean patient age was 48.9 ± 14.0 years. Hyperparathyroidism was the most common
indication for surgery (n= 10, 90.9%). Local disease was detected in 5 patients (45.5%), invasive disease was
detected in 5 patients (45.5%) and metastatic disease was detected in 1 patient (9.1%). The mean follow-up
period was 99.6± 42.1 months, and the patients’ average disease-free survival was 96.0± 49.0 months. During
the follow-up period, only 1 patient died of metastatic parathyroid carcinoma.
CONCLUSION: Parathyroid carcinoma has a slow-growing natural progression, and regional lymph node
metastases are uncommon. Although our study comprised few patients, it nevertheless showed that in selected
cases, parathyroid carcinoma could be solely treated with parathyroidectomy.
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’ INTRODUCTION
Parathyroid carcinoma is a rare parathyroid gland
malignancy, accounting for less than 1% (1) of primary
hyperparathyroidism cases. Although extremely high blood
calcium levels may indicate parathyroid carcinoma (2), it is
usually diagnosed through detailed pathological analysis
after surgery. Currently, surgery is the only effective and
curative treatment for parathyroid carcinoma. The goal of the
surgery (3) is to remove the tumor en bloc with any adherent
tissue and enlarged lymph nodes as well as the ipsilateral
thyroid lobe. In this study, based on our 12 years of
experience, we discuss the necessity for performing a thyroid
lobectomy in cases of parathyroid carcinoma.
’ MATERIALS AND METHODS
Eleven patients diagnosed with parathyroid carcinoma
between 2000 and 2012 were included in our study.
Demographics, previous neck surgery history, parathyroi-
dectomy indications, surgery type, disease duration, follow-
up periods, disease-free survival, pathological findings, and
metastatic disease presence were retrospectively evaluated.
’ RESULTS
Of the 522 patients who underwent parathyroid surgery at
the Department of Endocrine Surgery at Ankara University
Medical School, 11 had parathyroid carcinoma (a 2.1% ratio).
The patient demographic data are provided in Table 1.
The mean patient age was 48.9 ± 14.0 years. Seven of the
patients were male (63.6%), and the mean age of the male
patients was 53.3 ± 12.0 years. The mean age of the female
patients was 41.3 ± 15.7 years. Two of the patients had
undergone a previous thyroidectomy (18.2%). Although
hyperparathyroidism was the most common indication for
surgery (n = 10, 90.9%), suspected parathyroid carcinoma
(n = 3), papillary thyroid carcinoma (PTC) (n = 2), and
nodular goiter (n = 1) were also indications for the surgery
(Table 1).
Parathyroidectomy was performed on each patient. The
surgical procedures and pathological analysis results are
shown in Table 2. Frozen sections were obtained from 5
patient samples, revealing suspected malignancy in 4
patients and parathyroid cancer in 1 patient. Parathyroidect-
omy was used as a stand-alone procedure in 5 patients;DOI: 10.6061/clinics/2015(04)05
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based on pathological analyses, 3 of these patients had local
disease, and 2 had invasive disease. Due to a suspicion of
parathyroid cancer, ipsilateral thyroid lobectomy with frozen
section analysis was performed on 3 patients, one of whom
had nodular goiter. Total thyroidectomies were also per-
formed on 3 patients, 2 with PTC and 1 with metastatic
parathyroid cancer. Central neck dissection was performed
in 4 of 11 patients, and lymph node metastasis was
histopathologically detected in only 1 case.
According to pathological analyses, 5 patients (45.5%) had
local disease, 5 patients (45.5%) had invasive disease, and
only 1 patient (9.1%) had metastatic disease. The mean
follow-up period was 99.6 ± 42.1 months. Only 1 patient
died of metastatic parathyroid carcinoma, and death occurred
37 months after diagnosis. Locoregional or systemic recurrence
did not occur in any of the patients during follow-up.
’ DISCUSSION
Parathyroid carcinoma is an infrequent malignant disease
of the parathyroid glands. Parathyroid carcinoma occurs
with an annual incidence of approximately 1.25 cases per
10,000,000 persons (4) and accounts for less than 1% of
primary hyperparathyroidism cases (1,5). Parathyroid carci-
noma can be difficult to preoperatively diagnose (6,7) due to
the similarity of its clinical features to benign diseases.
However, a patient with hyperparathyroidism might have
parathyroid carcinoma because these malignant tumors
produce massive quantities of parathyroid hormone, greater
than those produced by benign parathyroid tumors (adeno-
mas or hyperplasia). All patients with hyperparathyroidism
have elevated parathyroid hormone levels in their blood;
those with benign disease tend to have levels in the
‘‘hundreds,’’ whereas those with parathyroid cancer tend
to have values in the ‘‘thousands,’’ with a parathyroid
hormone level that is commonly 3 to 10 times the upper limit
of the normal range (7–9). Patients with normal serum
calcium and parathyroid hormone levels (10) should not be
excluded from a suspected prediagnosis of parathyroid
carcinoma because nonfunctional parathyroid carcinomas
are also observed, with an incidence of less than 10% of
parathyroid carcinomas (11). In our study, nonfunctional
parathyroid carcinoma was found in 1 patient (9.2%), and
this patient underwent surgery due to papillary thyroid
carcinoma and suspected parathyroid carcinoma. The major-
ity of parathyroid carcinomas are hormonally active (7) and
usually exhibit symptoms and complications of hyperpar-
athyroidism due to elevated parathyroid hormone levels.
However, we only operated on 1 out of 10 patients who were
admitted to our clinic with hyperparathyroidism symptoms
during the course of our study.
A survival analysis for parathyroid carcinoma extrapolated
from cancer databases such as the Surveillance, Epidemiology
and End Results (SEER) database, the National Cancer Data
Base (NCDB), and the Swedish Cancer Registry and from
longitudinal retrospective studies showed overall survival rates
of 85% and 49–77% (6) at 5- and 10-year follow-up, respectively.
In our study, 1 patient died in the 37th month of the follow-up,
and all of the other 10 patients were followed for a period of at
least 5 years (mean follow-up period 99.6± 42.1 months). The
5-year survival rate of our patients was 90.9%, which was
greater than that indicated in the literature. This may be
explained by the low number of patients included in our study
or because our surgical procedures were performed earlier than
those in the literature. Furthermore, 5 of our patients had over
10 years of disease-free survival.
Parathyroid carcinoma usually presents between 45 and 59
years of age (7) and occurs with equal distribution in males
and females. We determined a mean age of 48.9 ± 14.0
years, with 4 of the patients being less than 45 years of age
(19, 36, 37, and 42 years); these data differ from the literature
(7). Therefore, a parathyroid cancer diagnosis must be
considered for younger patients with hyperparathyroidism.
Surgical treatment is essential for parathyroid carcinoma
(12, 13). Preoperative suspicion and intraoperative recogni-
tion of parathyroid carcinoma require en bloc tumor
resection (3,14). Regional lymph node metastases are not
common, but a compartmental dissection (14) must be
performed if any lymph nodes are enlarged. Adjacent
thyroid lobe removal has also been recommended (15,16).
We performed ipsilateral thyroid lobectomy on 3 patients,
total thyroidectomy on 3 patients, and central lymph node
dissection on 4 patients. Parathyroidectomy alone was
performed on 5 patients. These 5 patients were closely
followed, and no residual or recurrent disease was detected.
Local disease was histopathologically identified in 3 patients,
and locally invasive disease was observed in 2 patients.
Thus, parathyroidectomy may be appropriate as a stand-
alone procedure for the treatment of parathyroid carcinoma
in selected cases, but these patients should be followed
closely. However, based on the available literature, courage is
required to diverge from the standard procedure of
performing en bloc resection for parathyroid carcinoma if
its presence is suspected.
In conclusion, parathyroid carcinoma has a slow-growing
natural progression, and regional lymph node metastases are
uncommon. Although the data in the literature compel us to
perform ipsilateral thyroid lobectomies, our results showed
that parathyroid carcinoma could be treated with parathyr-
oidectomy alone in select cases. This result must be further
evaluated in larger studies.
Table 1 - Demographic features and indications for
surgery of parathyroid carcinoma patients.
Mean age (y) 48.9±14
Male (n= 7) 53.3±12
Female (n= 4) 41.3±15.7
Gender
Male 63.6%
Female 36.4%
Indications for parathyroidectomy (n, %)
Hyperparathyroidism 10 (90.9%)
Suspected parathyroid carcinoma 3 (27.3%)
Papillary thyroid carcinoma 2 (18.2%)
Nodular goiter 1 (9.1%)
Table 2 - Surgical procedures and pathological diagnoses.
Surgical procedures Number of patients (%)
Parathyroidectomy (stand-alone procedure) 5 (45.5%)
Parathyroidectomy + Thyroid lobectomy 1 (9.1%)
Parathyroidectomy +Thyroid lobectomy
+ Unilateral central lymph node dissection
2 (18.2%)
Parathyroidectomy + Total thyroidectomy 1 (9.1%)
Parathyroidectomy + Total thyroidectomy
+ Central lymph node dissection
2 (18.2%)
Pathological diagnoses
Parathyroid carcinoma 11 (100%)
Nodular goiter 1 (9.1%)
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Table 3 - Patient characteristics.
Patient Age Previous
operation
Indications for
parathyroidectomy
Frozen section Surgical treatment Extent of
disease
Pathological
findings
Follow-up
period
(months)
1 42 None HPT, nodular goiter Suspected
malignancy
Thyroid lobectomy,
parathyroidectomy, and
central lymph node
dissection
Invasive Nodular goiter and
locally invasive
parathyroid
carcinoma
139
2 36 None HPT, parathyroid
carcinoma
Malignant TT, parathyroidectomy,
and central lymph node
dissection
Metastatic Invasive parathyroid
carcinoma
37
3 64 None HPT None Parathyroidectomy Local Parathyroid
carcinoma
149
4 37 None PTC, suspected
parathyroid
carcinoma
Suspected
malignancy
TT, parathyroidectomy,
and central lymph node
dissection
Invasive PTC and invasive
parathyroid
carcinoma
138
5 19 None HPT None Parathyroidectomy Local Parathyroid
carcinoma
79
6 56 None HPT Suspected
malignancy
Thyroid lobectomy and
parathyroidectomy
Local Parathyroid
carcinoma
134
7 56 None HPT Suspected
malignancy
Thyroid lobectomy,
parathyroidectomy and
central lymph node
dissection
Invasive Invasive parathyroid
carcinoma
140
8 65 None HPT, PTC None TT and parathyroidectomy Local Papillary thyroid
carcinoma and
parathyroid
carcinoma
83
9 54 TT HPT None Parathyroidectomy Invasive Parathyroid
carcinoma
86
10 59 TT HPT None Parathyroidectomy Invasive Parathyroid
carcinoma
36
11 50 None HPT None Parathyroidectomy Local Parathyroid
carcinoma
75
HPT: hyperparathyroidism, TT: total thyroidectomy, PTC: papillary thyroid carcinoma.
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